Yes oldngrey, CVac has been developed as a platform drug to treat a number of cancers (breast, ovarian, prostate, lung and colon).
The early steps of extending the research to other indiactions will be confirming the method of action in the ICS data that's about to be released.
Ovarian is the first cab off the rank due to its unmet need; so is the softer target in terms of approvals.
strong support, page-15
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |